{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:50:36Z","timestamp":1790182236469,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T00:00:00Z","timestamp":1477699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["Nos. 21791985 and 23592883"],"award-info":[{"award-number":["Nos. 21791985 and 23592883"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00784-016-1986-x","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T11:36:26Z","timestamp":1477740986000},"page":"1979-1988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Secretomes from mesenchymal stem cells participate in the regulation of osteoclastogenesis in vitro"],"prefix":"10.1007","volume":"21","author":[{"given":"Kenichi","family":"Ogata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,29]]},"reference":[{"key":"1986_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","volume":"11","author":"PD Delmas","year":"2008","unstructured":"Delmas PD (2008) Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. J Clin Densitom 11:325\u2013338. doi: 10.1016\/j.jocd.2008.02.002","journal-title":"J Clin Densitom"},{"key":"1986_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000151371","volume":"189","author":"MR Allen","year":"2009","unstructured":"Allen MR (2009) Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Cells Tissues Organs 189:289\u2013294. doi: 10.1159\/000151371","journal-title":"Cells Tissues Organs"},{"key":"1986_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, Trial F (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765. doi: 10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"key":"1986_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","volume":"29","author":"DH Henry","year":"2011","unstructured":"Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R, Yeh H (2011) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29:1125\u20131132. doi: 10.1200\/JCO.2010.31.3304","journal-title":"J Clin Oncol"},{"key":"1986_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677\u2013692. doi: 10.1016\/j.bone.2010.11.020","journal-title":"Bone"},{"key":"1986_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on denosumab. J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 68:959\u2013963. doi: 10.1016\/j.joms.2009.10.010","journal-title":"J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg"},{"key":"1986_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","volume":"48","author":"KH Taylor","year":"2010","unstructured":"Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg 48:221\u2013223. doi: 10.1016\/j.bjoms.2009.08.030","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1986_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/adj.12217","volume":"59","author":"M O\u2019Halloran","year":"2014","unstructured":"O\u2019Halloran M, Boyd NM, Smith A (2014) Denosumab and osteonecrosis of the jaws\u2014the pharmacology, pathogenesis and a report of two cases. Aust Dent J 59:516\u2013519. doi: 10.1111\/adj.12217","journal-title":"Aust Dent J"},{"key":"1986_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","volume":"19","author":"WX Qi","year":"2014","unstructured":"Qi WX, Tang LN, He AN, Yao Y, Shen Z (2014) Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol 19:403\u2013410. doi: 10.1007\/s10147-013-0561-6","journal-title":"Int J Clin Oncol"},{"key":"1986_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.oooo.2015.07.017","volume":"120","author":"TM You","year":"2015","unstructured":"You TM, Lee KH, Lee SH, Park W (2015) Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics. Oral Surg Oral Med Oral Pathol Oral Radiol 120:548\u2013553. doi: 10.1016\/j.oooo.2015.07.017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1986_CR11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"1986_CR12","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jbmr.37","volume":"25","author":"T Kikuiri","year":"2010","unstructured":"Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W, Wang S, Le AD, Shi S (2010) Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 25:1668\u20131679. doi: 10.1002\/jbmr.37","journal-title":"J Bone Miner Res"},{"key":"1986_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bone.2012.04.020","volume":"51","author":"C Pautke","year":"2012","unstructured":"Pautke C, Kreutzer K, Weitz J, Knodler M, Munzel D, Wexel G, Otto S, Hapfelmeier A, Sturzenbaum S, Tischer T (2012) Bisphosphonate related osteonecrosis of the jaw: a minipig large animal model. Bone 51:592\u2013599. doi: 10.1016\/j.bone.2012.04.020","journal-title":"Bone"},{"key":"1986_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","volume":"68","author":"RS Molon de","year":"2014","unstructured":"de Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, Aghaloo TL, Tetradis S (2014) Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone 68:11\u201319. doi: 10.1016\/j.bone.2014.07.027","journal-title":"Bone"},{"key":"1986_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bone.2015.01.011","volume":"74","author":"K Ogata","year":"2015","unstructured":"Ogata K, Katagiri W, Osugi M, Kawai T, Sugimura Y, Hibi H, Nakamura S, Ueda M (2015) Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model. Bone 74:95\u2013105. doi: 10.1016\/j.bone.2015.01.011","journal-title":"Bone"},{"key":"1986_CR16","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1634\/stemcells.2006-0686","volume":"25","author":"SC Hung","year":"2007","unstructured":"Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ (2007) Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25:2363\u20132370. doi: 10.1634\/stemcells.2006-0686","journal-title":"Stem Cells"},{"key":"1986_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.scr.2011.01.004","volume":"6","author":"A Oskowitz","year":"2011","unstructured":"Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R (2011) Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6:215\u2013225. doi: 10.1016\/j.scr.2011.01.004","journal-title":"Stem Cell Res"},{"key":"1986_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1089\/ten.TEA.2011.0325","volume":"18","author":"M Osugi","year":"2012","unstructured":"Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M (2012) Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A 18:1479\u20131489. doi: 10.1089\/ten.TEA.2011.0325","journal-title":"Tissue Eng Part A"},{"key":"1986_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbrc.2012.11.074","volume":"430","author":"T Inukai","year":"2013","unstructured":"Inukai T, Katagiri W, Yoshimi R, Osugi M, Kawai T, Hibi H, Ueda M (2013) Novel application of stem cell-derived factors for periodontal regeneration. Biochem Biophys Res Commun 430:763\u2013768. doi: 10.1016\/j.bbrc.2012.11.074","journal-title":"Biochem Biophys Res Commun"},{"key":"1986_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.11607\/jomi.3036","volume":"28","author":"W Katagiri","year":"2013","unstructured":"Katagiri W, Osugi M, Kawai T, Ueda M (2013) Novel cell-free regeneration of bone using stem cell-derived growth factors. Int J Oral Maxillofac Implants 28:1009\u20131016. doi: 10.11607\/jomi.3036","journal-title":"Int J Oral Maxillofac Implants"},{"key":"1986_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/ID.0000000000000335","author":"W Katagiri","year":"2015","unstructured":"Katagiri W, Osugi M, Kinoshita K, Hibi H (2015) Conditioned medium from mesenchymal stem cells enhances early bone regeneration after maxillary sinus floor elevation in rabbits. Implant Dent. doi: 10.1097\/ID.0000000000000335","journal-title":"Implant Dent"},{"key":"1986_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jcyt.2014.11.009","volume":"17","author":"T Kawai","year":"2015","unstructured":"Kawai T, Katagiri W, Osugi M, Sugimura Y, Hibi H, Ueda M (2015) Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy 17:369\u2013381. doi: 10.1016\/j.jcyt.2014.11.009","journal-title":"Cytotherapy"},{"key":"1986_CR23","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2015.0104","author":"Y Sugimura-Wakayama","year":"2015","unstructured":"Sugimura-Wakayama Y, Katagiri W, Osugi M, Kawai T, Ogata K, Sakaguchi K, Hibi H (2015) Peripheral nerve regeneration by secretomes of stem cells from human exfoliated deciduous teeth. Stem Cells Dev doi. doi: 10.1089\/scd.2015.0104","journal-title":"Stem Cells Dev doi"},{"key":"1986_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001886","volume":"3","author":"L Chen","year":"2008","unstructured":"Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886. doi: 10.1371\/journal.pone.0001886","journal-title":"PLoS One"},{"key":"1986_CR25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889\u2013901","journal-title":"Dev Cell"},{"key":"1986_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm1515","volume":"12","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H (2006) Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 12:1410\u20131416. doi: 10.1038\/nm1515","journal-title":"Nat Med"},{"key":"1986_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/art.38218","volume":"66","author":"K Yokota","year":"2014","unstructured":"Yokota K, Sato K, Miyazaki T, Kitaura H, Kayama H, Miyoshi F, Araki Y, Akiyama Y, Takeda K, Mimura T (2014) Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol 66:121\u2013129. doi: 10.1002\/art.38218","journal-title":"Arthritis Rheumatol"},{"key":"1986_CR28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gr.6.10.995","volume":"6","author":"UE Gibson","year":"1996","unstructured":"Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6:995\u20131001","journal-title":"Genome Res"},{"key":"1986_CR29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","volume":"6","author":"CA Heid","year":"1996","unstructured":"Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986\u2013994","journal-title":"Genome Res"},{"key":"1986_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","volume":"13","author":"G Neufeld","year":"1999","unstructured":"Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9\u201322","journal-title":"FASEB J"},{"key":"1986_CR31","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.biomaterials.2004.07.051","volume":"26","author":"M Hossain","year":"2005","unstructured":"Hossain M, Irwin R, Baumann MJ, McCabe LR (2005) Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials 26:2595\u20132602. doi: 10.1016\/j.biomaterials.2004.07.051","journal-title":"Biomaterials"},{"key":"1986_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.onc.1208223","volume":"24","author":"K Kishimoto","year":"2005","unstructured":"Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445\u2013456. doi: 10.1038\/sj.onc.1208223","journal-title":"Oncogene"},{"key":"1986_CR33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.bbrc.2006.02.100","volume":"342","author":"JS Yao","year":"2006","unstructured":"Yao JS, Zhai W, Young WL, Yang GY (2006) Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 342:1396\u20131404. doi: 10.1016\/j.bbrc.2006.02.100","journal-title":"Biochem Biophys Res Commun"},{"key":"1986_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1634\/stemcells.2006-0293","volume":"25","author":"S Schenk","year":"2007","unstructured":"Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM, Penn MS (2007) Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25:245\u2013251. doi: 10.1634\/stemcells.2006-0293","journal-title":"Stem Cells"},{"key":"1986_CR35","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1074\/jbc.M802139200","volume":"283","author":"J Niu","year":"2008","unstructured":"Niu J, Azfer A, Zhelyabovska O, Fatma S, Kolattukudy PE (2008) Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 283:14542\u201314551. doi: 10.1074\/jbc.M802139200","journal-title":"J Biol Chem"},{"key":"1986_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10456-008-9127-z","volume":"12","author":"JS McGonigle","year":"2009","unstructured":"McGonigle JS, Giachelli CM, Scatena M (2009) Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. Angiogenesis 12:35\u201346. doi: 10.1007\/s10456-008-9127-z","journal-title":"Angiogenesis"},{"key":"1986_CR37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/nm.2542","volume":"17","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S (2011) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 17:1594\u20131601. doi: 10.1038\/nm.2542","journal-title":"Nat Med"},{"key":"1986_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/stem.1040","volume":"30","author":"P Guihard","year":"2012","unstructured":"Guihard P, Danger Y, Brounais B, David E, Brion R, Delecrin J, Richards CD, Chevalier S, Redini F, Heymann D, Gascan H, Blanchard F (2012) Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling. Stem Cells 30:762\u2013772. doi: 10.1002\/stem.1040","journal-title":"Stem Cells"},{"key":"1986_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1172\/JCI43027","volume":"122","author":"Y Ishida","year":"2012","unstructured":"Ishida Y, Kimura A, Kuninaka Y, Inui M, Matsushima K, Mukaida N, Kondo T (2012) Pivotal role of the CCL5\/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J Clin Investig 122:711\u2013721. doi: 10.1172\/JCI43027","journal-title":"J Clin Investig"},{"key":"1986_CR40","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.bbamcr.2013.06.025","volume":"1833","author":"JE Huh","year":"2013","unstructured":"Huh JE, Lee SY (2013) IL-6 is produced by adipose-derived stromal cells and promotes osteogenesis. Biochim Biophys Acta 1833:2608\u20132616. doi: 10.1016\/j.bbamcr.2013.06.025","journal-title":"Biochim Biophys Acta"},{"key":"1986_CR41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02563795","volume":"41","author":"PR Elford","year":"1987","unstructured":"Elford PR, Felix R, Cecchini M, Trechsel U, Fleisch H (1987) Murine osteoblastlike cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture. Calcif Tissue Int 41:151\u2013156","journal-title":"Calcif Tissue Int"},{"key":"1986_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H Yoshida","year":"1990","unstructured":"Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442\u2013444. doi: 10.1038\/345442a0","journal-title":"Nature"},{"key":"1986_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"1986_CR44","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.173.8.4838","volume":"173","author":"H Kitaura","year":"2004","unstructured":"Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL (2004) Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173:4838\u20134846","journal-title":"J Immunol"},{"key":"1986_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589\u2013595. doi: 10.1084\/jem.20050978","journal-title":"J Exp Med"},{"key":"1986_CR46","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F, American Association of O, Maxillofacial S (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956. doi: 10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1986-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T04:32:25Z","timestamp":1568521945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1986-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,29]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1986-x","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,29]]}}}